Clinical Trial Update: A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is assessing whether rasagiline changes sense of smell in patients with Parkinson's disease; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: The Parkinson's Institute | Conditions: Parkinson's Disease | Phase 4 | Status: UNKNOWN